Best of IBD Summit: Establishing a Foundation to Improve the Quality of IBD Care

2.00 CME
120 MINS
$0 FEE
SAVE
Best of IBD Summit: Establishing a Foundation to Improve the Quality of IBD Care

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by educational grants from AbbVie, Inc.; Pfizer, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.


Activity Description

Inflammatory bowel disease (IBD), of which Crohn’s disease and ulcerative colitis are the 2 main subtypes, is a chronic, relapsing condition characterized by an overly active immune response to the gut enteric flora, resulting in bowel inflammation and ulceration. IBD has a detrimental effect on quality of life for patients who suffer from this disease. Despite the increasing prevalence of IBD, gastroenterology fellows receive inadequate education regarding the diagnosis, classification, and management of these patients. Now in its third year, the IBD Summit for Fellows featured expert faculty who discussed optimal strategies for providing care to patients with IBD. Highlights from that program are presented here.


Target Audience

The intended audience for the activity is gastroenterology fellows and other health care professionals involved in the management of patients with IBD.


Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Assess the clinical safety and efficacy of available and emerging treatments for IBD.
  • Review the importance of adherence to established quality measures for IBD management for both providers and patients.
  • Evaluate the components of effective treat-to-target approach for patients with IBD.

Activity Co-chairs

David T. Rubin, MD
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL

Corey A. Siegel, MD, MS
Professor of Medicine and of the Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine at Dartmouth
Section Chief, Gastroenterology and Hepatology
Co-director, Dartmouth-Hitchcock Inflammatory Bowel Disease Center
Lebanon, NH


Faculty

Jonathan A. Leighton, MD, FACG
Professor of Medicine, Division of Gastroenterology and Hepatology
Vice Chair, Department of Medicine
Mayo Clinic Arizona
Phoenix, AZ

Gary R. Lichtenstein, MD
Professor of Medicine
Raymond and Ruth Perelman School of Medicine
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
University of Pennsylvania and University of Pennsylvania Health System
Philadelphia, PA

Millie D. Long, MD, MPH
Associate Professor of Medicine
Director, Gastroenterology and Hepatology Fellowship Program
Vice-Chief for Education
University of North Carolina at Chapel Hill
Division of Gastroenterology and Hepatology
Chapel Hill, NC

Miguel Regueiro, MD
Chair, Department of Gastroenterology and Hepatology
The Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology
Vice Chair, Digestive Disease and Surgery Institute
Professor of Medicine
Cleveland Clinic
Cleveland, OH


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, January 21, 2020, through January 20, 2021.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the activity, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of 5 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.


Activity Co-chairs and Faculty report the following relationship(s)

Jonathan A. Leighton, MD, FACG
Consulting Fee: Olympus
Contracted Research: Pfizer, Theravance Biopharma
Other Disclosure: Advisory Board: Check-Cap

Gary R. Lichtenstein, MD
Royalty: SLACK Incorporated
Consulting Fee: AbbVie, Celgene, Cellcuetix, Endo Pharmaceuticals, Ferring, Gilead, Janssen, Lilly, Luitpold/American Regent, Merck, Morphic Therapeutic, Pfizer, Prometheus, Romark, Salix/Valeant, Shire, Takeda, UCB
Contracted Research: Celgene, Janssen, Salix/Valeant, Shire, UCB
Other Disclosure: Consulting Fee (paid to institution): Janssen, Pfizer, Takeda
Data and Safety Monitoring Board: Lilly
Author Honoraria: McMahon Publishing, UpToDate
Editor Honoraria: American College of Gastroenterology, Clinical Advances in Gastroenterology, Gastro-Hep Communications, Springer Science and Business Media

Millie D. Long, MD, MPH
Consulting Fee: AbbVie, Janssen, Pfizer, Prometheus, Salix, Takeda, Target PharmaSolutions, UCB, Valeant
Speakers Bureau: AbbVie, UCB
Contracted Research: Pfizer, Takeda

Miguel Regueiro, MD
Consulting Fee: AbbVie, Amgen, Celgene, Janssen, Miraca Labs, Pfizer, Seres Therapeutics, Takeda, UCB
Contracted Research: AbbVie, Janssen, Takeda
Unrestricted Educational Grants: AbbVie, Janssen, Pfizer, Salix, Shire, Takeda, UCB

David T. Rubin, MD, FACG, AGAF, FACP, FASGE
Consulting Fee: AbbVie, AbGenomics, Allergan, Biomica, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Check-Cap, Dizal Pharmaceutical, GalenPharma/Atlantica, Genentech/Roche, Gilead, GlaxoSmithKline, Glenmark, Janssen, Lilly, Mahana Therapeutics, Medtronic, Narrow River Management, Pfizer, Prometheus, Reistone, Seres Therapeutics, Shire, Takeda, Target PharmaSolutions
Contracted Research: AbbVie, Genentech/Roche, Janssen, Prometheus, Shire, Takeda
Ownership Interest: Cornerstones Health, Inc., GoDuRun, LLC
Board of Trustees: American College of Gastroenterology

Corey A. Siegel, MD, MS
Consulting Fee: AbbVie, Amgen, Celgene, Janssen, Lilly, Pfizer, Prometheus, Sandoz, Sebela, Takeda
Contracted Research: AbbVie, Janssen, Pfizer, Takeda
Other: Dartmouth-Hitchcock Medical Center and Cedars-Sinai Medical Center have a patent pending for a “System and Method of Communicating Predicted Medical Outcomes”, filed 3/24/10. Dr. Corey Siegel and Dr. Lori Siegel are inventors and co-founders of MiTest Health, LLC. Patent pending for “Dietary Purgatives”, filed 7/9/2009. Dr. Corey Siegel is an inventor and co-founder of ColonaryConcepts, LLC


Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.


Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com